Picture of Procter & Gamble Health logo

PGHL Procter & Gamble Health Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeMid CapHigh Flyer

Annual cashflow statement for Procter & Gamble Health, fiscal year end - June 30th, INR millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:18 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3,5492,3332,5343,1422,733
Depreciation
Non-Cash Items-416-4.82.3134249
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1,073-156-1,112-1,197-973
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,3542,4731,6952,3602,283
Capital Expenditures-233-526-379-425-217
Purchase of Fixed Assets
Other Investing Cash Flow Items1,879203124210149
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities1,646-323-255-215-68.7
Financing Cash Flow Items-1,5020
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-8,834-3,866-2,886-985-4,181
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-4,834-1,716-1,4461,160-1,967